Side effects of GLP-1 agonists commonly include gastrointestinal discomfort, but careful management and consideration of contraindications are essential for safe and effective treatment
Clinical research shows that Zepbound can help patients achieve significant weight loss when combined with a healthy diet and increased physical activity
For that, see Provns article on how GLP-1 medications work for weight loss
Using them alongside these changes gives the best results
The minimum BMI for semaglutide (Wegovy) under FDA labeling is 30 without any additional conditions, or 27 with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia
But unlike natural GLP-1, which decays very rapidly (its half-life is just 2 minutes), synthetic GLP-1 receptor agonists are long-acting and remain active in your body for hours or days